A primer on the design, conduct, and interpretation of clinical trials

被引:23
作者
Appel, Lawrence J.
机构
[1] Johns Hopkins Univ, Dept Med, Baltimore, MD 21205 USA
[2] Johns Hopkins Univ, Dept Epidemiol, Baltimore, MD 21205 USA
[3] Johns Hopkins Univ, Dept Int Hlth Human Nutr, Baltimore, MD 21205 USA
来源
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY | 2006年 / 1卷 / 06期
关键词
D O I
10.2215/CJN.02850806
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Clinical trials are an especially powerful study design that often guides health care policy and clinical practice. Indeed, well-designed and rigorously conducted trials can establish the etiologic relevance of modifiable risk factors and the benefits (and risks) of candidate therapies. Contemporary schema that classify evidence place results from randomized trials at the pinnacle of evidence. The primary objective of this article is to provide an overview of the design, conduct, and interpretation of trials with an emphasis on aspects that are relevant to nephrology.
引用
收藏
页码:1360 / 1367
页数:8
相关论文
共 20 条
[1]  
[Anonymous], 1991, JAMA, V265, P3255
[2]  
Appel LJ, 2003, JAMA-J AM MED ASSOC, V289, P2083, DOI 10.1001/jama.289.16.2083
[3]   A clinical trial of the effects of dietary patterns on blood pressure [J].
Appel, LJ ;
Moore, TJ ;
Obarzanek, E ;
Vollmer, WM ;
Svetkey, LP ;
Sacks, FM ;
Bray, GA ;
Vogt, TM ;
Cutler, JA ;
Windhauser, MM ;
Lin, PH ;
Karanja, N .
NEW ENGLAND JOURNAL OF MEDICINE, 1997, 336 (16) :1117-1124
[4]   Principal results of the Controlled Onset Verapamil Investigation of Cardiovascular End Points (CONVINCE) Trial [J].
Black, HR ;
Elliott, WJ ;
Grandits, G ;
Grambsch, P ;
Lucente, T ;
White, WB ;
Neaton, JD ;
Grimm, RH ;
Hansson, L ;
Lacourcière, Y ;
Muller, J ;
Sleight, P ;
Weber, MA ;
Williams, G ;
Wittes, J ;
Zanchetti, A ;
Anders, RJ .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2003, 289 (16) :2073-2082
[5]  
CANNER PL, 1980, NEW ENGL J MED, V303, P1038
[6]   BIAS IN TREATMENT ASSIGNMENT IN CONTROLLED CLINICAL-TRIALS [J].
CHALMERS, TC ;
CELANO, P ;
SACKS, HS ;
SMITH, H .
NEW ENGLAND JOURNAL OF MEDICINE, 1983, 309 (22) :1358-1361
[7]   Sequential therapies for proliferative lupus nephritis [J].
Contreras, G ;
Pardo, V ;
Leclercq, B ;
Lenz, O ;
Tozman, E ;
O'Nan, P ;
Roth, D .
NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (10) :971-980
[8]   Effect of dialysis dose and membrane flux in maintenance hemodialysis. [J].
Eknoyan, G ;
Beck, GJ ;
Cheung, AK ;
Daugirdas, JT ;
Greene, T ;
Kusek, JW ;
Allon, M ;
Bailey, J ;
Delmez, JA ;
Depner, TA ;
Dwyer, JT ;
Levey, AS ;
Levin, NW ;
Milford, E ;
Ornt, DB ;
Rocco, MV ;
Schulman, G ;
Schwab, SJ ;
Teehan, BP ;
Toto, R .
NEW ENGLAND JOURNAL OF MEDICINE, 2002, 347 (25) :2010-2019
[9]   The ethics of placebo-controlled trials - A middle ground. [J].
Emanuel, EJ ;
Miller, FG .
NEW ENGLAND JOURNAL OF MEDICINE, 2001, 345 (12) :915-919
[10]   Surrogate end points in clinical trials: Are we being misled? [J].
Fleming, TR ;
DeMets, DL .
ANNALS OF INTERNAL MEDICINE, 1996, 125 (07) :605-613